Addressing unmet needs in inflammatory bowel disease
- 1 September 2015
- journal article
- Published by Elsevier in Drug Discovery Today
- Vol. 20 (9) , 1037-1039
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2015
- Ferric Maltol Is Effective in Correcting Iron Deficiency Anemia in Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2015
- European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel DiseasesJournal of Crohn's and Colitis, 2015
- IBD and health-related quality of life — Discovering the true impactJournal of Crohn's and Colitis, 2014
- Iron deficiency: the hidden miscreant in inflammatory bowel disease.Current Drug Targets, 2014
- Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: An online IBD registryJournal of Crohn's and Colitis, 2013
- Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases#Inflammatory Bowel Diseases, 2007
- Ferric trimaltol corrects iron deficiency anaemia in patients intolerant of ironAlimentary Pharmacology & Therapeutics, 1998
- ABSORPTION OF LOW AND THERAPEUTIC DOSES OF FERRIC MALTOL, A NOVEL FERRIC IRON COMPOUND, IN IRON DEFICIENT SUBJECTS USING A SINGLE DOSE IRON ABSORPTION TESTJournal of Clinical Pharmacy and Therapeutics, 1991